Opioid use in Ankylosing spondylitis major risk of fracture

Ankylosing spondylitis (AS) is a rare type of arthritis that mainly affects the back, by causing inflammation in the spine. AS occurs more frequently in men than women (2:1). Mostly known to peak in the second and third decades of life. Approximately 80% of patients with AS experience symptoms at ≤ 30 years of age, while only 5% will present with symptoms at ≥ 45 years of age.

Researchers in a large cohort study published in Arthritis Care and Research journal evaluated the incidence rate and factors associated with fractures among adults with ankylosing spondylitis (AS). The study found that with increasing age, historical fracture, and use of opioids led to higher risk of fracture. Men and women both were equally likely to have a fracture.

The retrospective cohort study with data from the Rheumatology Informatics System for Effectiveness (RISE) registry linked to Medicare claims from 2016-2018. Patients were required to have two AS ICD codes, ≥30 days apart, and a subsequent Medicare claim. Then, one year of baseline characteristics were included, after which patients were observed for fractures. First, they calculated the incidence rate of fractures. Secondly constructed logistic regression models to identify factors associated with fracture, including age, sex, race/ethnicity, body mass index, Medicare/Medicaid dual-eligibility, area deprivation index, Charlson comorbidity index, smoking status, osteoporosis, historical fracture, and use of osteoporosis treatment, glucocorticoids, and opioids.